openPR Logo
Press release

Anti-radiation Drugs Market Projected to Reach US$ 9.6 Billion by 2031, Exhibiting a Significant 9.9% CAGR

02-06-2024 02:10 PM CET | Health & Medicine

Press release from: Transparency Market Research

Anti-radiation Drugs Market

Anti-radiation Drugs Market

The global anti-radiation drugs market was valued at US$ 3.4 billion in 2021 and is anticipated to grow at a CAGR of 9.9% from 2022 to 2031. This growth is driven by the increasing demand for medications that prevent the concentration and absorption of radioactive iodide in the human thyroid gland, such as Prussian Blue, Diethylenetriamine pentaacetate (DTPA), and potassium iodide (KI).

Increased demand: Growing need for medications to prevent the concentration and absorption of radioactive iodide in the human thyroid gland is a primary driver of market growth.

Nuclear proliferation: Escalating concerns regarding potential nuclear catastrophes due to the proliferation of nuclear weapons and warheads globally are spurring nations to intensify efforts in developing radiation countermeasures.

Get a Sample Copy of the Anti-radiation Drugs Market Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85240&utm_source=OpenPR_Ajay&utm_medium=OpenPR

Key Findings:

Increase in Acute Radiation Syndrome Prevalence: The acute radiation syndrome (ARS) segment dominated the industry in 2021. ARS is a critical factor in public health and welfare in radiological or nuclear incidents.

Growing Need for Potassium Iodide Products: Potassium iodide (KI) segment led the global market in 2021. KI compounds are highly effective in protecting against harmful radiations and are widely used in the radiopharmaceuticals sector.

Companies Profiled: Key players include Amgen Inc., Anbex Inc., Arco Pharmaceuticals LLC, BTG International Inc., Cellphire, Inc., among others.

Market Segmentation:

Compound: Potassium Iodide (KI), Prussian Blue, DTPA (Diethylenetriamine Pentaacetate), Others

Application: Acute Radiation Syndrome (ARS), Cancer Treatment, Radiation Exposure, Others

Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others

Geographical Coverage:

North America: United States, Canada, Mexico

Europe: Germany, UK, France, Italy, Russia, Turkey, etc.

Asia-Pacific: China, Japan, Korea, India, Australia, Southeast Asia

South America: Brazil, etc.

Middle East and Africa: North Africa, GCC Countries

Key Features of the Report:

Competitive Developments: Expansions, deployments, new product launches, and market acquisitions.

Market Opportunities: Identification of higher growth segments for stakeholders.

Global Industry Analysis: In-depth examination of key regions and SWOT analysis.

Strategic Recommendations: Insights for incumbents and new entrants to gain a competitive advantage.

Comprehensive Analysis: Key product segments, application spectrum, and market dynamics are analyzed.

Inquire more about this report before purchase - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=85240&utm_source=OpenPR_Ajay&utm_medium=OpenPR

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-radiation Drugs Market Projected to Reach US$ 9.6 Billion by 2031, Exhibiting a Significant 9.9% CAGR here

News-ID: 3374459 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$